The HeadquartersCorporate ProfileThe OrganisationFIVB Story
Volleyball StoryChronological HighlightsBeach Volleyball OriginsRulesFundamentals
CompetitionsCalendarWorld RankingsOfficial RulesOfficial FormsVolleyball Story
CompetitionsPlayer BiosWorld RankingsRulesFormsBeach Volleyball OriginsRefereeing
Volleyball Cooperation Programme (VCP)Development CentresTechnical e-libraryTechnical Video EvaluationU-VolleyInternational CooperationMini/School VolleyballPark Volley
Contact l RSS RSS Facebook Twitter YouTube l Login
NEWS

FIVB provides warning to athletes regarding supplements

 
Athletes must be very careful when using any supplement because, under the World Anti-Doping Code's policy of strict liability, they are responsible for any substance found in their body
 

Lausanne, Switzerland, February 18, 2011 - The International Volleyball Federation (FIVB) is once more warning its athletes to carefully consider their use of supplements following a number of positive test results for the prohibited stimulant methylhexaneamine. Methylhexaneamine has been the subject of a number of recent international doping cases with some athletes involved reporting that they unknowingly ingested the banned substance when using supplements or other products.

Methylhexaneamine, also referred to as dimethylamylamine and dimethylpentylamine, is classed as an S6 stimulant on the World Anti-Doping Agency's Prohibited List and is prohibited In-competition. Athletes must be very careful when using any supplement because, under the World Anti-Doping Code's policy of strict liability, they are responsible for any substance found in their body.

In addition, the Manfred Donike Institute for Doping Analysis (MDI) and the Centre for Preventive Doping Research of the German Sport University Cologne are warning athletes of the risks of inadvertent doping with the β2-agonist clenbuterol when travelling to China. Results of an investigation show the following: "An investigation, presented on 14 February 2011 at the Cologne Workshop on Doping Analysis, showed that the analyses of the urine samples of 28 travellers, returning from China to Germany, resulted in findings of low concentrations of the doping substance clenbuterol in 22 out of the 28 urine samples.

"The results were obtained between 15 September and 15 January 2011. The findings are most probably due to a food contamination problem, potentially caused by misuse of clenbuterol as growth promoter in stock-breeding."

For more information contact medical@fivb.org.





 Language(s)
   English

 Additional links
   Download high-resolution photo
   FIVB home page
   Medical home page

LATEST NEWS

Latest headlines